J-Pharma Uniphar Development Press Release
J-Pharma Co., Ltd. and Uniphar Development, LLC Announce Advancement of Nanvuranlat into Phase 3 Clinical Development Following FDA Alignment and Initial Patient Enrollment Strategic partnership enables
J-Pharma Co., Ltd. and Uniphar Development, LLC Announce Advancement of Nanvuranlat into Phase 3 Clinical Development Following FDA Alignment and Initial Patient Enrollment Strategic partnership enables